/PGNY
PGNY Stock - Progyny, Inc.
Healthcare|Medical - Healthcare Information ServicesNASDAQ
$25.24-11.19%
$3.18 (-11.19%) • Jan 13
78
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.68
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).98
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.83
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+23.8%upside
Target: $31.25
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PGNY
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$24.99 – $25.49
TARGET (TP)$31.25
STOP LOSS$23.22
RISK/REWARD1:3.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.94
52W High$28.75
52W Low$17.98
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.17B | $1.09B | $786.91M | $500.62M | $344.86M |
| Gross Profit | $253.36M | $238.80M | $167.32M | $112.14M | $70.06M |
| Gross Margin | 21.7% | 21.9% | 21.3% | 22.4% | 20.3% |
| Operating Income | $67.45M | $62.18M | $23.34M | $32.34M | $8.35M |
| Net Income | $54.34M | $62.04M | $30.36M | $65.77M | $46.46M |
| Net Margin | 4.7% | 5.7% | 3.9% | 13.1% | 13.5% |
| EPS | $0.59 | $0.65 | $0.33 | $0.74 | $0.54 |
Company Overview
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PGNYBeat Rate
100%
Last 18 quarters
Avg Surprise
+124.5%
EPS vs Estimate
Beats / Misses
18/0
Last 12 quarters
Latest EPS
$0.45
Q4 2025
EPS Surprise History
Q1 24
+190.9%
$0.32vs$0.11
Q2 24
+178.6%
$0.39vs$0.14
Q3 24
+19.4%
$0.43vs$0.36
Q4 24
+8.1%
$0.40vs$0.37
Q1 25
+13.5%
$0.42vs$0.37
Q2 25
+6.7%
$0.48vs$0.45
Q3 25
+9.1%
$0.48vs$0.44
Q4 25
+15.4%
$0.45vs$0.39
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Feb 26, 2026 | $0.38 | — | — | — |
Q4 2025 | Nov 6, 2025 | $0.39 | $0.45 | +15.4% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $0.44 | $0.48 | +9.1% | ✓ BEAT |
Q2 2025 | May 8, 2025 | $0.45 | $0.48 | +6.7% | ✓ BEAT |
Q1 2025 | Feb 27, 2025 | $0.37 | $0.42 | +13.5% | ✓ BEAT |
Q4 2024 | Nov 12, 2024 | $0.37 | $0.40 | +8.1% | ✓ BEAT |
Q3 2024 | Aug 6, 2024 | $0.36 | $0.43 | +19.4% | ✓ BEAT |
Q2 2024 | May 9, 2024 | $0.14 | $0.39 | +178.6% | ✓ BEAT |
Q1 2024 | Feb 27, 2024 | $0.11 | $0.32 | +190.9% | ✓ BEAT |
Q4 2023 | Nov 7, 2023 | $0.12 | $0.16 | +33.3% | ✓ BEAT |
Q3 2023 | Aug 3, 2023 | $0.10 | $0.15 | +50.0% | ✓ BEAT |
Q2 2023 | May 8, 2023 | $0.07 | $0.18 | +157.1% | ✓ BEAT |
Q1 2023 | Feb 27, 2023 | $0.01 | $0.03 | +157.1% | ✓ BEAT |
Q4 2022 | Nov 3, 2022 | $0.05 | $0.13 | +160.0% | ✓ BEAT |
Q3 2022 | Aug 4, 2022 | $0.05 | $0.09 | +80.0% | ✓ BEAT |
Q2 2022 | May 5, 2022 | $0.01 | $0.05 | +525.0% | ✓ BEAT |
Q1 2022 | Feb 28, 2022 | $0.04 | $0.15 | +316.7% | ✓ BEAT |
Q4 2021 | Nov 4, 2021 | $0.06 | $0.17 | +183.3% | ✓ BEAT |
Q3 2021 | Aug 5, 2021 | $0.08 | $0.19 | +137.5% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about PGNY
What is PGNY's current stock price?
Progyny, Inc. (PGNY) is currently trading at $25.24 per share. The stock has moved -11.19% today.
What is the analyst price target for PGNY?
The average analyst price target for PGNY is $31.25, based on 1 analyst.
What sector is Progyny, Inc. in?
Progyny, Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NASDAQ exchange.
What is PGNY's market cap?
Progyny, Inc. has a market capitalization of $2.18 billion, making it a mid-cap company.
Does PGNY pay dividends?
No, Progyny, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALVO
Alvotech
$4.83
Mkt Cap: $1.5B
GDRX
GoodRx Holdings, Inc.
$2.86
Mkt Cap: $1.0B
OMCL
Omnicell, Inc.
$51.39
Mkt Cap: $2.4B
OMDA
Omada Health
$16.13
Mkt Cap: $0.9B
PHR
Phreesia, Inc.
$16.58
Mkt Cap: $1.0B
SDGR
Schrödinger, Inc.
$18.31
Mkt Cap: $1.3B
SEM
Select Medical Holdings Corporation
$14.91
Mkt Cap: $1.8B
TDOC
Teladoc Health, Inc.
$6.99
Mkt Cap: $1.2B
TXG
10x Genomics, Inc.
$20.52
Mkt Cap: $2.5B
UFPT
UFP Technologies, Inc.
$252.47
Mkt Cap: $1.9B
Explore stocks similar to PGNY for comparison